WA
CL icon

Wambolt & Associates’s Colgate-Palmolive CL Stock Holding History

Wambolt & Associates’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$267K Buy
2,899
+14
+0.5% +$1.28K 0.09% 156
2025
Q1 		$271K Buy
2,885
+14
+0.5% +$1.25K 0.09% 154
2024
Q4 		$261K Sell
2,871
-1,220
-30% -$116K 0.08% 163
2024
Q3 		$419K Buy
4,091
+8
+0.2% +$815 0.11% 134
2024
Q2 		$390K Sell
4,083
-115
-3% -$10.6K 0.11% 145
2024
Q1 		$374K Buy
4,198
+828
+25% +$70.2K 0.11% 163
2023
Q4 		$269K Buy
3,370
+17
+0.5% +$1.28K 0.09% 211
2023
Q3 		$237K Buy
3,353
+18
+0.5% +$1.35K 0.09% 217
2023
Q2 		$257K Sell
3,335
-106
-3% -$8.21K 0.09% 219
2023
Q1 		$259K Sell
3,441
-11
-0.3% -$818 0.09% 223
2022
Q4 		$272K Buy
3,452
+46
+1% +$3.45K 0.1% 197
2022
Q3 		$239K Buy
3,406
+16
+0.5% +$1.25K 0.1% 206
2022
Q2 		$272K Buy
3,390
+17
+0.5% +$1.33K 0.11% 200
2022
Q1 		$258K Buy
3,373
+13
+0.4% +$1.03K 0.09% 214
2021
Q4 		$287K Sell
3,360
-9
-0.3% -$703 0.1% 203
2021
Q3 		$255K Buy
3,369
+42
+1% +$3.33K 0.1% 209
2021
Q2 		$272K Buy
3,327
+15
+0.5% +$1.23K 0.12% 207
2021
Q1 		$260K Buy
3,312
+15
+0.5% +$1.18K 0.14% 189
2020
Q4 		$282K Buy
3,297
+14
+0.4% +$1.16K 0.17% 172
2020
Q3 		$253K Buy
3,283
+15
+0.5% +$1.14K 0.19% 162
2020
Q2 		$239K Buy
3,268
+16
+0.5% +$1.14K 0.19% 160
2020
Q1 		$216K Buy
+3,252
New +$229K 0.22% 146
2019
Q4 		– Sell
-2,732
Closed -$201K – 168
2019
Q3 		$201K Buy
+2,732
New +$198K 0.17% 153

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Wambolt & Associates's CL Position: Q2 2025 in Review

Wambolt & Associates increased its Colgate-Palmolive (CL) stake by 0.49% in Q2 2025, buying an estimated $1.28K and bringing the position to 2,899 shares worth $267K. The position accounts for 0.09% of the portfolio, ranked #156.

Wambolt & Associates first reported a position in CL in Q3 2019 and has held it in 23 quarters since. The position peaked at $419K in Q3 2024. 1,914 funds tracked by Wall St. Rank hold CL as of Q2 2025.

  • Wambolt & Associates held 2,899 shares of Colgate-Palmolive worth $267K as of Q2 2025.
  • Wambolt & Associates bought 14 Colgate-Palmolive shares in Q2 2025, an estimated $1.28K.
  • Colgate-Palmolive made up 0.09% of Wambolt & Associates's portfolio in Q2 2025, its #156 holding.
  • Wambolt & Associates first reported a position in Colgate-Palmolive in Q3 2019 and has held it in 23 quarters since.
  • Wambolt & Associates's Colgate-Palmolive position peaked at $419K in Q3 2024.
  • 1,914 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2025.

Based on Wambolt & Associates's 13F filing for Q2 2025, filed 13 Aug 2025.